Fatskills
Practice. Master. Repeat.
Study Guide: USMLE Reproductive: Testicular Tumors—Seminoma vs. NSGCT, Markers, Spread
Source: https://www.fatskills.com/usmle/chapter/usmle-reproductive-testicular-tumors-seminoma-vs-nsgct-markers-spread

USMLE Reproductive: Testicular Tumors—Seminoma vs. NSGCT, Markers, Spread

By Fatskills Exam Guides Team — the exam nerds behind 28,500+ quizzes and 2.1M practice questions across 500+ global exams.

⏱️ ~5 min read

What This Is and Why It Matters for USMLE

Testicular tumors, specifically seminoma and non-seminomatous germ cell tumors (NSGCT), are high-yield topics for Step 1 and Step 2 CK. They are relatively common in young men, and their management is critical due to the potential for testicular cancer to spread to other parts of the body. Understanding the differences between seminoma and NSGCT, as well as the role of tumor markers and patterns of spread, is essential for accurate diagnosis and treatment.

High-Yield Facts (What You Must Memorize)

  • Seminoma: most common type of testicular cancer, accounts for 40-50% of cases; typically presents in men aged 30-50; ?-fetoprotein (AFP) levels are usually normal; most commonly spreads to retroperitoneal lymph nodes.
  • NSGCT: accounts for 40-50% of testicular cancer cases; typically presents in men aged 20-40; AFP levels are often elevated; can spread to retroperitoneal lymph nodes, lungs, liver, and other sites.
  • Tumor markers: AFP, ?-human chorionic gonadotropin (?-hCG), and lactate dehydrogenase (LDH); elevated levels indicate tumor presence or recurrence.
  • Diagnostic approach: physical exam, ultrasound, and tumor marker levels; CT scans to evaluate retroperitoneal lymph nodes and other potential sites of spread.
  • First-line treatment: orchiectomy (surgical removal of the testicle) followed by chemotherapy (e.g., bleomycin, etoposide, and cisplatin) for seminoma; orchiectomy followed by chemotherapy (e.g., bleomycin, etoposide, and cisplatin) and possibly surgery or radiation for NSGCT.
  • Red flags, complications, and follow-up: watch for signs of metastasis (e.g., weight loss, abdominal pain, shortness of breath); monitor tumor marker levels and perform regular CT scans to evaluate response to treatment and detect recurrence.

Clinical Pearls & Buzzwords

  • "IgG4-related disease"-elevated IgG4 levels and lymphoplasmacytic infiltrate.
  • "Riedel's struma"-diffuse thyroiditis with fibrosis and potential airway compromise.
  • "Seminoma"-most common type of testicular cancer, typically presents in men aged 30-50.

Step-by-Step Clinical Reasoning

  1. Identify the syndrome or presentation: a young man with a firm, painless testicular mass.
  2. Generate a differential (most likely and must-not-miss): testicular cancer (seminoma or NSGCT), epididymitis, testicular torsion.
  3. Order appropriate initial tests: physical exam, ultrasound, tumor marker levels (AFP, ?-hCG, LDH).
  4. Interpret results: elevated AFP levels suggest NSGCT; normal AFP levels suggest seminoma.
  5. Initiate treatment and monitoring: orchiectomy followed by chemotherapy for seminoma; orchiectomy followed by chemotherapy and possibly surgery or radiation for NSGCT.

Common Mistakes & Exam Traps

  • The mistake: Failing to consider NSGCT in a young man with a testicular mass and elevated AFP levels.
  • Why it happens: Misunderstanding the typical presentation and tumor markers for seminoma and NSGCT.
  • How to avoid it: Remember that NSGCT can present with normal AFP levels, and always consider both seminoma and NSGCT in the differential diagnosis.
  • Exam board insight: The examiners will penalize you for not considering NSGCT in the differential diagnosis.

How It’s Tested on USMLE

  • Step 1: Basic science vignette: "A 25-year-old man presents with a firm, painless testicular mass; what is the most likely diagnosis?"
  • Step 2 CK: Clinical vignette: "A 35-year-old man with a history of testicular cancer presents with shortness of breath; what is the most likely diagnosis?"
  • Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.

CCS (Step 3) Relevance (If Applicable)

  • Initial orders: Order a CT scan of the chest, abdomen, and pelvis to evaluate for metastasis.
  • Monitoring and follow-up: Monitor tumor marker levels and perform regular CT scans to evaluate response to treatment and detect recurrence.
  • Common mistakes: Failing to order a CT scan of the chest, abdomen, and pelvis, or delaying treatment.

Practice Questions (3-5 single-best-answer)

Question 1: A 30-year-old man presents with a firm, painless testicular mass; what is the most likely diagnosis? Options: A) Seminoma, B) NSGCT, C) Epididymitis, D) Testicular torsion Answer: B) NSGCT Explanation: The patient's age and presentation suggest NSGCT, which is more common in young men.

Question 2: A 40-year-old man with a history of testicular cancer presents with shortness of breath; what is the most likely diagnosis? Options: A) Pulmonary embolism, B) Pleural effusion, C) Lymphoma, D) Metastatic testicular cancer Answer: D) Metastatic testicular cancer Explanation: The patient's history of testicular cancer and shortness of breath suggest metastasis to the lungs.

Question 3: A 25-year-old man presents with elevated AFP levels and a testicular mass; what is the most likely diagnosis? Options: A) Seminoma, B) NSGCT, C) Epididymitis, D) Testicular torsion Answer: B) NSGCT Explanation: Elevated AFP levels suggest NSGCT, which is more common in young men.

Quick Reference Card (60-Second Summary)

  • Seminoma: most common type of testicular cancer, presents in men aged 30-50, normal AFP levels.
  • NSGCT: accounts for 40-50% of testicular cancer cases, presents in men aged 20-40, elevated AFP levels.
  • Tumor markers: AFP, ?-hCG, and LDH; elevated levels indicate tumor presence or recurrence.
  • First-line treatment: orchiectomy followed by chemotherapy (e.g., bleomycin, etoposide, and cisplatin).
  • Red flags: watch for signs of metastasis (e.g., weight loss, abdominal pain, shortness of breath).

If You Get Stuck on Test Day

  • Eliminate obviously wrong answers: if the patient presents with a firm, painless testicular mass, options A and D are unlikely.
  • Use the "next best step" hierarchy: order a CT scan of the chest, abdomen, and pelvis to evaluate for metastasis.
  • For Step 3 CCS: order a CT scan of the chest, abdomen, and pelvis to evaluate for metastasis, and monitor tumor marker levels and perform regular CT scans to evaluate response to treatment and detect recurrence.

Related USMLE Topics

  • "Retroperitoneal fibrosis" connects to "IgG4-related disease" through their shared association with elevated IgG4 levels and lymphoplasmacytic infiltrate.
  • "Pulmonary embolism" connects to "Metastatic testicular cancer" through their shared presentation with shortness of breath.
  • "Lymphoma" connects to "Metastatic testicular cancer" through their shared potential for lymph node involvement.